104
Participants
Start Date
October 17, 2022
Primary Completion Date
December 15, 2023
Study Completion Date
December 15, 2023
Influenza vaccine
0.5 mL single-dose injection
Placebo
0.5 mL single-dose injection with no therapeutic effect
Clinical and Translation Research Center, Chapel Hill
Howell Hall, Chapel Hill
U.S. National Science Foundation
FED
University of North Carolina, Chapel Hill
OTHER